Less Ads, More Data, More Tools Register for FREE

e-Therapeutics Loss Narrows On Higher Revenue And Lower R&D Spend

Tue, 17th Mar 2020 15:10

(Alliance News) - e-Therapeutics PLC on Tuesday reported a narrowed annual loss largely due to lower research & development expenses and a sharp rise in revenue.

Revenue for the financial year ended January 31 rose sharply to GBP456,000 from GBP44,000.

The firm's pretax loss narrowed to GBP2.9 million from GBP5.1 million the year before as research & development spend fell to GBP2.1 million from GBP3.7 million.

e-Therapeutics said this lower R&D figure reflected "lower external spend on our self-funded NDD-derived assets in the year".

"We have instead focussed our R&D investment into improved platform functionality, which has included enhancements in the areas of mechanistic disease segmentation, target identification, MoA and, of course, our new GAINs technology. Enhancements of our technological capabilities will be further advanced in the coming year," the company said.

e-Therapeutics added the Covid-19 pandemic is not expected to materially alter the assumptions included in its budget.

Shares in e-Therapeutics were up 6.0% at 7.10 pence in London on Tuesday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News

TRADING UPDATES: ZAIM Credit launches app; Benchmark in Norway boost

TRADING UPDATES: ZAIM Credit launches app; Benchmark in Norway boost

2 Jul 21 17:37

E-therapeutics meets 'key milestone' in Galapagos collaboration

(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.

2 Jul 21 13:47

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

9 Jun 21 16:08

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

2 Jun 21 16:02

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.